PolyAn offers functionalized, transparent polymer beads with a very narrow particle size distribution for particle analysis using flow cytometry or other screening applications.
PolyAn can custom modify beads with antibodies, oligonucleotides and peptides, respectively.
Transparent, functionalised PMMA microparticle
Id | Mean Diameter | Surface Modifications | Packaging Volume |
105 10 002 |
2 µm | Low Aggregation | 4 mL / 5% |
105 10 005 |
5 µm | Low Aggregation | 4 mL / 5% |
105 10 009 |
9 µm | Low Aggregation | 4 mL / 5% |
105 10 012 |
12 µm | Low Aggregation | 4 mL / 5% |
105 10 016 |
16 µm | Low Aggregation | 4 mL / 5% |
105 10 020 |
20 µm | Low Aggregation | 4 mL / 5% |
105 11 002 |
2 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 005 |
5 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 009 |
9 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 012 |
12 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 016 |
16 µm | 3D-Carboxy AF | 4 mL / 5% |
105 11 020 |
20 µm | 3D-Carboxy AF | 4 mL / 5% |
105 21 002 |
2 µm | Streptavidin | 1.5 mL / 1% |
105 21 005 |
5 µm | Streptavidin | 1.5 mL / 1% |
105 21 009 |
9 µm | Streptavidin | 1.5 mL / 1% |
105 21 012 |
12 µm | Streptavidin | 1.5 mL / 1% |
105 21 016 |
16 µm | Streptavidin | 1.5 mL / 1% |
105 21 020 |
20 µm | Streptavidin | 1.5 mL / 1% |
105 22 002 |
2 µm | Neutravidin | 1.5 mL / 1% |
105 22 005 |
5 µm | Neutravidin | 1.5 mL / 1% |
105 22 009 |
9 µm | Neutravidin | 1.5 mL / 1% |
105 22 012 |
12 µm | Neutravidin | 1.5 mL / 1% |
105 22 016 |
16 µm | Neutravidin | 1.5 mL / 1% |
105 22 020 |
20 µm | Neutravidin | 1.5 mL / 1% |
105 24 002 |
2 µm | 3D-Alkyne | 1.5 mL / 1% |
105 24 005 |
5 µm | 3D-Alkyne | 1.5 mL / 1% |
105 24 009 |
9 µm | 3D-Alkyne | 1.5 mL / 1% |
105 24 012 |
12 µm | 3D-Alkyne | 1.5 mL / 1% |
105 24 016 |
16 µm | 3D-Alkyne | 1.5 mL / 1% |
105 24 020 |
20 µm | 3D-Alkyne | 1.5 mL / 1% |
105 27 002 |
2 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
105 27 005 |
5 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
105 27 009 |
9 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
105 27 012 |
12 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
105 27 016 |
16 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
105 27 020 |
20 µm | Oligonucleotide (customer specific) | 1.0 mL / 0.1% |
105 28 002 |
2 µm | Protein A/G | 1.5 mL / 1% |
105 28 005 |
5 µm | Protein A/G | 1.5 mL / 1% |
105 28 009 |
9 µm | Protein A/G | 1.5 mL / 1% |
105 28 012 |
12 µm | Protein A/G | 1.5 mL / 1% |
105 28 016 |
16 µm | Protein A/G | 1.5 mL / 1% |
105 28 020 |
20 µm | Protein A/G | 1.5 mL / 1% |
105 29 002 |
2 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
105 29 005 |
5 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
105 29 009 |
9 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
105 29 012 |
12 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
105 29 016 |
16 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
105 29 020 |
20 µm | Peptide (customer specific) | 1.0 mL / 0.1% |
108 35 002 |
2 µm | 3D-Azide | 1.5 mL / 1% |
108 35 005 |
5 µm | 3D-Azide | 1.5 mL / 1% |
108 35 009 |
9 µm | 3D-Azide | 1.5 mL / 1% |
108 35 012 |
12 µm | 3D-Azide | 1.5 mL / 1% |
108 35 016 |
16 µm | 3D-Azide | 1.5 mL / 1% |
108 35 020 |
20 µm | 3D-Azide | 1.5 mL / 1% |
108 36 002 |
2 µm | 3D-Aldehyde | 1.5 mL / 1% |
108 36 005 |
5 µm | 3D-Aldehyde | 1.5 mL / 1% |
108 36 009 |
9 µm | 3D-Aldehyde | 1.5 mL / 1% |
108 36 012 |
12 µm | 3D-Aldehyde | 1.5 mL / 1% |
108 36 016 |
16 µm | 3D-Aldehyde | 1.5 mL / 1% |
108 36 020 |
20 µm | 3D-Aldehyde | 1.5 mL / 1% |
PolyAn can custom modify beads with antibodies, oligonucleotides and peptides, respectively. In order to optimize the performance for your specific application, other particle sizes and functional groups with different loading capacities are available upon request. Please do not hesitate to contact us to discuss your application.